GNNSF (Genscript Biotech) Institutional Ownership: 18.29% (As of Jul. 30, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

GNNSF Genscript Biotech Corp GNNSF
72 GF Score
Price $2.00
GF Value $2.43
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Genscript Biotech Institutional Ownership?

Genscript Biotech GNNSF +9.89% 72 Institutional Ownership is 18.29% as of Jul. 30, 2026. GuruFocus rates GNNSF with a GF Score™ of 72/100 and a GF Value™ of $2.43 (Modestly Undervalued). The stock has 6 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Genscript Biotech's institutional ownership is 18.29%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Genscript Biotech's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Genscript Biotech's Float Percentage Of Total Shares Outstanding is 0.00%.

Genscript Biotech Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Genscript Biotech's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Genscript Biotech Institutional Ownership Chart

Genscript Biotech Historical Data

The historical data trend for Genscript Biotech can be seen below:

2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30
Institutional Ownership 17.32 16.92 16.99 19.54 19.63 20.07 19.97 20.12 20.21 20.75
GNNSF
72GF Score
Genscript Biotech Corp GNNSF
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Genscript Biotech Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 18.29% mean?
Genscript Biotech (GNNSF) has a Institutional Ownership of 18.29% as of Jul. 30, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Genscript Biotech and its competitors.
Is Genscript Biotech's Institutional Ownership too high?
Genscript Biotech's current Institutional Ownership is 18.29%. Overall, Genscript Biotech has a GF Score™ of 72/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Genscript Biotech's Institutional Ownership compare to VRTX and REGN?
Genscript Biotech's Institutional Ownership of 18.29% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Genscript Biotech and its competitors. Genscript Biotech's current Institutional Ownership is 18.29%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genscript Biotech stock overvalued right now?
Based on GuruFocus' analysis, Genscript Biotech (GNNSF) is currently considered Modestly Undervalued. The stock's GF Value™ is $2.43, compared to a current price of $2.00 — trading 17.7% below its estimated fair value. The current Institutional Ownership is 18.29%. Genscript Biotech's overall GF Score™ is 72/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Genscript Biotech (GNNSF), the current Institutional Ownership is 18.29% as of Jul. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Genscript Biotech (GNNSF) Overvalued in 2026?

Based on GuruFocus' analysis, Genscript Biotech stock appears to be undervalued. The current stock price of $2.00 is trading 17.7% below its estimated GF Value™ of $2.43. GuruFocus considers Genscript Biotech to be Modestly Undervalued.

Key valuation signals for GNNSF:

  • Institutional Ownership: 18.29%
  • GF Value™: $2.43 vs. price of $2.00 (17.7% below fair value)
  • GF Score™: 72/100 with 6 warning signs

No single metric tells the full story. See the GNNSF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Genscript Biotech Business Description

Other Exchanges 01548:Hong KongG51:Germany
Address 860 Centennial Avenue, Piscataway, NJ, USA, 08854
GenScript Biotech Corp is an investment holding company engaged in the manufacture and sale of life science research products and services, including life science services and products, biologics development services, and industrial synthetic biology products. Its segments include life science services and products, which generate maximum revenue and provide research services and products; biologics development services, which support the development of therapeutic antibodies and CGT products; industrial synthetic biology, which provides enzyme development and production using engineered microbial strains; and the operation unit, which provides shared services. It operates in Mainland China, which generates maximum revenue, U.S., Europe, and the Asia Pacific excluding Mainland China.
72GF Score

Get the complete analysis for GNNSF

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.00
Price
$2.43
GF Value